Oaktree Acquisition Corp. III Life Sciences (OACC) Non Operating Income (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Non Operating Income of $1.9 million for Q1 2026, down 12.02% on a YoY basis from $2.1 million in Q1 2025, and down 9.48% quarter-over-quarter from $2.0 million in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Non Operating Income (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Non Operating Income for 2 years, with the latest figure at $1.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 12.02% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $8.2 million (changed N/A YoY), and the FY2025 full-year result was $8.5 million, up 403.98% from the prior year.
  • Non Operating Income for Q1 2026 stood at $1.9 million, down from $2.0 million in the prior quarter.
  • The five-year high for Non Operating Income was $2.2 million in Q3 2025, with the low at $1.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 4.31 Mn
2 Berto Acquisition 312.46 Mn 312.46 Mn - -
3 Centurion Acquisition 311.65 Mn 311.65 Mn - 2.72 Mn
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 2.98 Mn
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 2.65 Mn
6 WEN Acquisition 309.15 Mn 309.15 Mn - -
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 2.37 Mn
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - -
9 BTC Development 262.16 Mn 262.16 Mn - -
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - 1.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.85 Mn
Dec 31, 2025 2.04 Mn
Sep 30, 2025 2.19 Mn
Jun 30, 2025 2.14 Mn
Mar 31, 2025 2.10 Mn